Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models

BACKGROUND: The live-attenuated yellow fever vaccine YF17D holds great promise as alternative viral vector vaccine platform, showcased by our previously presented potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate YF-S0. Besides protection from SARS-CoV-2, YF-S0 al...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ji, Yakass, Michael Bright, Jansen, Sander, Malengier-Devlies, Bert, Van Looveren, Dominique, Sanchez-Felipe, Lorena, Vercruysse, Thomas, Weynand, Birgit, Javarappa, Mahadesh Prasad Arkalagud, Quaye, Osbourne, Matthys, Patrick, Roskams, Tania, Neyts, Johan, Thibaut, Hendrik Jan, Dallmeier, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419561/
https://www.ncbi.nlm.nih.gov/pubmed/36041265
http://dx.doi.org/10.1016/j.ebiom.2022.104240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419561/
https://www.ncbi.nlm.nih.gov/pubmed/36041265
http://dx.doi.org/10.1016/j.ebiom.2022.104240

Ejemplares similares